Clinical Trial

Multimodal Prognostic Assessment of Acute Ischemic Stroke Patients With Atrial Fibrillation: a Prospective, Multicenter, Observational Study (IAT-CLOSURE)

Recruiting
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to investigate the safety and outcomes of different treatment strategies, including best medical therapy (OAC \[oral anticoagulation\], antiplatelet \[APT\]) and left atrial appendage closure \[LAAC\] in acute ischemic stroke (AIS) patients with atrial fibrillation (AF) based on multimodal assessment from combined brain and cardiologic work-up, and to optimize secondary prevention.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-08-07; most recent amendment 2025-05-19.
Status change: Not Yet Recruiting → Recruiting 2024-12-23
Trial Details
NCT Number NCT06548269
Lead Sponsor Jinan Central Hospital
Conditions Acute Ischemic Stroke, Atrial Fibrillation
Enrollment 1,000 participants
Start Date 2024-11-15
Primary Completion 2027-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-22